Nan Chen

Also affiliated with University of Chicago Medicine Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.”.

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13103

N/A

0DataRank · unranked

3 citations

Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn, Frederick M. Howard +8 more

Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy

Clinical Journal of the American Society of Nephrology(2024)10.2215/cjn.0000000000000422

N/A

0DataRank · unranked

10 citations

Jing Xu, Wei Wang, Lili Liu, Yuanmeng Jing, Chenni Gao +13 more